A History of Innovation Careers at MCPHS University Mission & Core Values Notable Facts & Statistics Leadership Our Directory Accreditation Giving Important Notices Contact

Our Directory


David Albers, PhD
Director, BS in Pharmacology & Toxicology program

School of Pharmacy - W331


School of Pharmacy - Boston

Pharmaceutical and Healthcare Business (BS)
Pharmacology (MS/PhD)
Pharmacology & Toxicology (BS)
Pharmacy (PharmD)

PhD, Rutgers University
BA, Washington University in St. Louis, Missouri

Areas of Teaching
Principles of Toxicology
Basic Pharmacology
Pharmacology and Toxicology Seminar
Analytical Methods in Pharmacology and Toxicology

Scholarly Interests
Oxidative stress/damage
Mitochondrial Dysfunction
Drug Development
Drug Discovery
Neurological Disease

Peer-Reviewed Articles & Book Chapters
Weiss, S.W., Albers, D.S., Iadarola, M.J., Dawson, T.D., Dawson, V.L. and Standaert, D.G. (1998) NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical and hippocampal nitric oxide synthase neurons. J. Neurosci. 18(5), 1725-1734.

Albers, D.S. and Sonsalla, P.K. (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity: Pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275, 1104-1114.

Albers, D.S., Augood, S.J., Martin, D.M., Standaert, D.G., Vonsattel, J.-P.G. and Beal, M.F. (1999) Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy. J. Neurochem. 73(2), 881-884.

Albers, D.S. and Beal, M.F. (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural Transm. 59 [Suppl], 133-154.

Lorenzl, S., Albers, D.S., Narr, S., Chirichigno, J.W. and Beal, M.F. (2002) Expression of MMP-2, MMP-9 and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's Disease. Exp. Neurol. 178, 13-20.

Chirichigno, J.W., Manfredi, G., Beal, M.F. and Albers, D.S. (2002) Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids. Brain Res. 951, 31-35.

Yang, L., Sugama, S., Chirichigno, J.W., Gregorio, J., Lorenzl, S., Shin, D.H., Browne, S.E., Shimizu, Y., Joh, T.H., Beal, M.F. and Albers, D.S. (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J. Neurosci. Res. 74, 278-285

Sugama, S., Yang, L., Cho, B.P., DeGiorgio, L.A., Lorenzl, S., Albers, D.S., Beal, M.F., Volpe, B.T. and Joh, T.H. (2003) Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res. 964, 288-94.

Lorenzl, S., Albers, D.S., LeWitt, P.A., Chirichigno, J.W., Hilgenberg, S.L., Cudkowicz, M.E. and Beal, M.F. (2003) Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J. Neurol. Sci. 207, 71-76.